110 related articles for article (PubMed ID: 28712115)
1. Expression of interferon regulatory factor 7 correlates with the expression of Epstein-Barr Virus latent membrane protein 1 and cervical lymph node metastasis in nasopharyngeal cancer.
Kondo S; Endo K; Wakisaka N; Aga M; Kano M; Seishima N; Imoto T; Kobayashi E; Moriyama-Kita M; Nakanishi Y; Murono S; Pagano JS; Yoshizaki T
Pathol Int; 2017 Sep; 67(9):461-466. PubMed ID: 28712115
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of EBV proteins LMP1 and BHFR1 in EBV‑associated gastric and nasopharyngeal cancer tissues.
Wang A; Zhang W; Jin M; Zhang J; Li S; Tong F; Zhou Y
Mol Med Rep; 2016 May; 13(5):4151-8. PubMed ID: 27052804
[TBL] [Abstract][Full Text] [Related]
3. Colocalization of interferon regulatory factor 7 (IRF7) with latent membrane protein 1 (LMP1) of Epstein-Barr virus.
Kim IW; Park HS
J Korean Med Sci; 2006 Jun; 21(3):379-84. PubMed ID: 16778376
[TBL] [Abstract][Full Text] [Related]
4. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit.
Ning S; Hahn AM; Huye LE; Pagano JS
J Virol; 2003 Sep; 77(17):9359-68. PubMed ID: 12915551
[TBL] [Abstract][Full Text] [Related]
5. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma.
Horikawa T; Yang J; Kondo S; Yoshizaki T; Joab I; Furukawa M; Pagano JS
Cancer Res; 2007 Mar; 67(5):1970-8. PubMed ID: 17332324
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
[TBL] [Abstract][Full Text] [Related]
7. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.
Yu PH; Chou SF; Chen CL; Hung H; Lai CY; Yang PM; Jeng YM; Liaw SF; Kuo HH; Hsu HC; Chen JY; Wang WB
PLoS One; 2013; 8(12):e82254. PubMed ID: 24340011
[TBL] [Abstract][Full Text] [Related]
9. Association of Plasma Epstein-Barr Virus LMP1 and EBER1 with Circulating Tumor Cells and the Metastasis of Nasopharyngeal Carcinoma.
Sun L; Wang Y; Shi J; Zhu W; Wang X
Pathol Oncol Res; 2020 Jul; 26(3):1893-1901. PubMed ID: 31832991
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Significance of IGF-1R and Relationship with Epstein-Barr Virus Markers: LMP1 and EBERs in Tunisian Patients with Nasopharyngeal Carcinoma.
Baizig NM; Wided BA; Amine OE; Gritli S; ElMay M
Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):1011-1019. PubMed ID: 32468823
[TBL] [Abstract][Full Text] [Related]
11. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
12. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma.
Horikawa T; Yoshizaki T; Sheen TS; Lee SY; Furukawa M
Cancer; 2000 Aug; 89(4):715-23. PubMed ID: 10951332
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma.
Shao JY; Ernberg I; Biberfeld P; Heiden T; Zeng YX; Hu LF
Anticancer Res; 2004; 24(4):2309-18. PubMed ID: 15330177
[TBL] [Abstract][Full Text] [Related]
15. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression.
Ma N; Kawanishi M; Hiraku Y; Murata M; Huang GW; Huang Y; Luo DZ; Mo WG; Fukui Y; Kawanishi S
Int J Cancer; 2008 Jun; 122(11):2517-25. PubMed ID: 18307254
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
17. Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit.
Ning S; Huye LE; Pagano JS
J Virol; 2005 Sep; 79(18):11671-6. PubMed ID: 16140744
[TBL] [Abstract][Full Text] [Related]
18. EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas.
Khabir A; Karray H; Rodriguez S; Rosé M; Daoud J; Frikha M; Boudawara T; Middeldorp J; Jlidi R; Busson P
Virol J; 2005 Apr; 2():39. PubMed ID: 15842731
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma.
Yoshizaki T; Kondo S; Wakisaka N; Murono S; Endo K; Sugimoto H; Nakanishi S; Tsuji A; Ito M
Cancer Lett; 2013 Aug; 337(1):1-7. PubMed ID: 23689138
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo.
Lin MC; Lin YC; Chen ST; Young TH; Lou PJ
BMC Cancer; 2017 Jan; 17(1):18. PubMed ID: 28056887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]